Overactive Bladder
📧 Sign up to get email alerts when something new happens for Overactive Bladder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2024-10-16Clinical Trial Update: Laser Treatment of Genito-urinary Syndrome in Women [NA]
A clinical trial investigating laser treatment for genitourinary syndrome of menopause in women has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Laser Therapy for Treatment of Urogenital Symptoms in Women
A completed clinical trial evaluated laser therapy for urogenital symptoms in women; results have been posted.
-
CLINICAL_TRIALS research · 2024-10-16Clinical Trial Update: A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)
A multicenter prospective observational study evaluating outcomes after initiation of a new treatment for overactive bladder; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: PTNS for Female Patients Suffering From Multiple Sclerosis [NA]
Terminated clinical trial evaluating percutaneous tibial nerve stimulation (PTNS) in female patients with multiple sclerosis (including over…
-
FDA approval · 2024-10-08FDA Approved: GEMTESA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for GEMTESA (vibegron) submitted by Sumitomo Pharma America, Inc., resulting in updated labeling.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1 [Phase 4]
Phase 4 trial update on combining darifenacin with parasacral transcutaneous electrical nerve stimulation for overactive bladder in HTLV-1 i…
-
CLINICAL_TRIALS research · 2024-09-27Clinical Trial Update: Transcutaneous Tibial Nerve Stimulation for Overactive Bladder Syndrome and Associated Gait Changes in Post-menopausal Women [NA]
A clinical trial update describes an upcoming study evaluating transcutaneous tibial nerve stimulation for overactive bladder and related ga…
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: Behavioral or Solifenacin Therapy for Urinary Symptoms in Parkinson Disease [Phase 3]
Phase 3 trial evaluating solifenacin therapy for urinary symptoms in Parkinson disease completed with results posted.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: OptiLUTS Part C: the Development of a Symptom Assessment Tool in Sacral Neuromodulation.
This clinical trial update details the development of a symptom assessment tool for sacral neuromodulation. It is sponsored by University Ho…
-
CLINICAL_TRIALS trial_result · 2024-09-04Clinical Trial Update: Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder [Phase 4]
Phase 4 trial reports on the safety and efficacy of oxybutynin topical gel in children with neurogenic bladder.
-
FDA approval · 2024-08-27FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Dr.Reddy's Laboratories Inc.,)
FDA approved a supplemental application for fesoterodine fumarate from Dr. Reddy's Laboratories, indicating regulatory approval of a modific…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: Botulinum Neurotoxin Type A (BoNT-A) in Paediatric Non-neurogenic Therapy Resistant Overactive Bladder (OAB)
A pediatric study evaluating botulinum toxin type A for non-neurogenic, therapy-resistant overactive bladder has completed; the trial is spo…
-
FDA approval · 2024-08-27FDA Approved: TOLTERODINE TARTRATE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a generic tolterodine tartrate product (ANDA 216917) from Unichem Pharmaceuticals (USA), Inc. for the treatment of overacti…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Extension Study of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia [Phase 3]
Extension Phase 3 study of vibegron for overactive bladder in men on BPH therapy has completed and results have been posted.
-
CLINICAL_TRIALS research · 2024-08-20Clinical Trial Update: Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
This clinical trial investigates urinary neurotrophin levels as potential biomarkers for overactive bladder using a case-control design; the…
-
CLINICAL_TRIALS research · 2024-08-19Clinical Trial Update: Vaginal Estradiol vs Oral Beta-3 Agonist for Overactive Bladder Syndrome [Phase 4]
A Phase 4 clinical trial is evaluating vaginal estradiol versus an oral beta-3 agonist for overactive bladder and is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-16Clinical Trial Update: Tibial Nerve Stimulation for Post-BPH Overactive Bladder [Phase 3]
Phase 3 clinical trial evaluating tibial nerve stimulation for persistent overactive bladder symptoms after benign prostatic hyperplasia sur…
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Stress and Anxiety Effects on Overactive Bladder
The clinical trial NCT05087810 at Vanderbilt University Medical Center was terminated while studying the effects of stress and anxiety on ov…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: AURA-2: Augmenting Urinary Reflex Activity [NA]
The AURA-2 clinical trial investigating augmentation of urinary reflex activity for overactive bladder and urge incontinence has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Treatment of REfractory Overactive BLadder With the AXonics Sacral Neuromodulation System (RELAX-OAB) [NA]
The RELAX-OAB clinical trial evaluating the AXonics Sacral Neuromodulation System for refractory overactive bladder has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men With Overactive Bladder (OAB) Symptoms on Pharmacological Therapy for Benign Prostatic Hyperplasia (BPH) [Phase 3]
Phase 3 trial assessing efficacy, safety, and tolerability of vibegron in men with overactive bladder on BPH therapy has completed, with res…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Real-life Clinical Experience With Ialuadapter Study
This clinical trial update reports real-world experience with the Ialuadapter, in patients with interstitial cystitis, overactive bladder, a…
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: NeuroGyn Genital Neuromodulation System for iOAB Treatment [NA]
Clinical trial update indicates the NeuroGyn Genital Neuromodulation System for overactive bladder is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Urinary Cytokines in Patients With Overactive Bladder (OAB)
A completed clinical trial evaluating urinary cytokines in patients with overactive bladder has posted results as of 2024-07-29. The trial i…
-
FDA approval · 2024-07-26FDA Approved: FESOTERODINE FUMARATE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved a supplemental application for fesoterodine fumarate submitted by Alembic Pharmaceuticals Inc. Fesoterodine fumarate is use…